415 related articles for article (PubMed ID: 33141146)
1. Cortical disinhibition in Parkinson's disease.
Ammann C; Dileone M; Pagge C; Catanzaro V; Mata-Marín D; Hernández-Fernández F; Monje MHG; Sánchez-Ferro Á; Fernández-Rodríguez B; Gasca-Salas C; Máñez-Miró JU; Martínez-Fernández R; Vela-Desojo L; Alonso-Frech F; Oliviero A; Obeso JA; Foffani G
Brain; 2020 Dec; 143(11):3408-3421. PubMed ID: 33141146
[TBL] [Abstract][Full Text] [Related]
2. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
[TBL] [Abstract][Full Text] [Related]
3. Increased facilitation of the primary motor cortex in de novo Parkinson's disease.
Shirota Y; Ohminami S; Tsutsumi R; Terao Y; Ugawa Y; Tsuji S; Hanajima R
Parkinsonism Relat Disord; 2019 Sep; 66():125-129. PubMed ID: 31327628
[TBL] [Abstract][Full Text] [Related]
4. Non-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia.
Barbin L; Leux C; Sauleau P; Meyniel C; Nguyen JM; Pereon Y; Damier P
Parkinsonism Relat Disord; 2013 Feb; 19(2):165-70. PubMed ID: 23000298
[TBL] [Abstract][Full Text] [Related]
5. Enhancing Gamma Oscillations Restores Primary Motor Cortex Plasticity in Parkinson's Disease.
Guerra A; Asci F; D'Onofrio V; Sveva V; Bologna M; Fabbrini G; Berardelli A; Suppa A
J Neurosci; 2020 Jun; 40(24):4788-4796. PubMed ID: 32430296
[TBL] [Abstract][Full Text] [Related]
6. Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation.
Berardelli A; Rona S; Inghilleri M; Manfredi M
Brain; 1996 Feb; 119 ( Pt 1)():71-7. PubMed ID: 8624695
[TBL] [Abstract][Full Text] [Related]
7. Neurophysiological correlates of bradykinesia in Parkinson's disease.
Bologna M; Guerra A; Paparella G; Giordo L; Alunni Fegatelli D; Vestri AR; Rothwell JC; Berardelli A
Brain; 2018 Aug; 141(8):2432-2444. PubMed ID: 29901693
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study.
Strafella AP; Valzania F; Nassetti SA; Tropeani A; Bisulli A; Santangelo M; Tassinari CA
Clin Neurophysiol; 2000 Jul; 111(7):1198-202. PubMed ID: 10880793
[TBL] [Abstract][Full Text] [Related]
9. Impaired intracortical transmission in G2019S leucine rich-repeat kinase Parkinson patients.
Ponzo V; Di Lorenzo F; Brusa L; Schirinzi T; Battistini S; Ricci C; Sambucci M; Caltagirone C; Koch G
Mov Disord; 2017 May; 32(5):750-756. PubMed ID: 28186666
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in Parkinson's disease: A transcranial magnetic stimulation study.
Kolmancic K; Perellón-Alfonso R; Pirtosek Z; Rothwell JC; Bhatia K; Kojovic M
Mov Disord; 2019 Dec; 34(12):1873-1881. PubMed ID: 31603570
[TBL] [Abstract][Full Text] [Related]
11. Study of cerebello-thalamocortical pathway by transcranial magnetic stimulation in Parkinson's disease.
Carrillo F; Palomar FJ; Conde V; Diaz-Corrales FJ; Porcacchia P; Fernández-Del-Olmo M; Koch G; Mir P
Brain Stimul; 2013 Jul; 6(4):582-9. PubMed ID: 23318222
[TBL] [Abstract][Full Text] [Related]
12. The mechanisms of interhemispheric inhibition in the human motor cortex.
Daskalakis ZJ; Christensen BK; Fitzgerald PB; Roshan L; Chen R
J Physiol; 2002 Aug; 543(Pt 1):317-26. PubMed ID: 12181302
[TBL] [Abstract][Full Text] [Related]
13. Changes in thresholds for intracortical excitability in chronic stroke: more than just altered intracortical inhibition.
Edwards JD; Meehan SK; Linsdell MA; Borich MR; Anbarani K; Jones PW; Ferris J; Boyd LA
Restor Neurol Neurosci; 2013; 31(6):693-705. PubMed ID: 23963339
[TBL] [Abstract][Full Text] [Related]
14. Substantia nigra echomorphology and motor cortex excitability.
Todd G; Taylor JL; Baumann D; Butler JE; Duma SR; Hayes M; Carew-Jones F; Piguet O; Behnke S; Ridding MC; Berg D; Double KL
Neuroimage; 2010 May; 50(4):1351-6. PubMed ID: 20117219
[TBL] [Abstract][Full Text] [Related]
15. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP
Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443
[TBL] [Abstract][Full Text] [Related]
16. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
[TBL] [Abstract][Full Text] [Related]
17. Impaired motor cortical facilitatory-inhibitory circuit interaction in Parkinson's disease.
Saravanamuttu J; Radhu N; Udupa K; Baarbé J; Gunraj C; Chen R
Clin Neurophysiol; 2021 Oct; 132(10):2685-2692. PubMed ID: 34284974
[TBL] [Abstract][Full Text] [Related]
18. Continuous Dopaminergic Stimulation Improves Cortical Maladaptive Changes in Advanced Parkinson's Disease.
Kolmančič K; Zupančič NK; Trošt M; Flisar D; Kramberger MG; Pirtošek Z; Kojović M
Mov Disord; 2022 Jul; 37(7):1465-1473. PubMed ID: 35436354
[TBL] [Abstract][Full Text] [Related]
19. Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease.
Cunic D; Roshan L; Khan FI; Lozano AM; Lang AE; Chen R
Neurology; 2002 Jun; 58(11):1665-72. PubMed ID: 12058096
[TBL] [Abstract][Full Text] [Related]
20. Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson's disease.
Dileone M; Carrasco-López MC; Segundo-Rodriguez JC; Mordillo-Mateos L; López-Ariztegui N; Alonso-Frech F; Catalan-Alonso MJ; Obeso JA; Oliviero A; Foffani G
Sci Rep; 2017 Jun; 7(1):4329. PubMed ID: 28659614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
